DIFFERENCES BETWEEN INDIAN-GCP AND ICH-GCP
1
INDEX
1> Introduction: Good Clinical Practice (GCP)
2> Differences b/w Indian-GCP & ICH-GCP.
3> Conclusion.
4> References.
2
INTRODUCTION
Good clinical practice (GCP) is an
international ethical & scientific quality
standard for designing, conducting ,
recording & reporting trials that involve the
participation of human subjects. Compliance
with standard provides public assurance that
the rights, safety & well being of trial
subjects are protected, consistent with the
principle that have their origin in the
Declaration of Helsinki, and that the clinical
trial data are credible. 3
The Indian version of GCP is based on the
ICH-GCP, but there are key differences
between the two. Some of the guidelines
found in the Indian version result in the
difficult methodology which becomes
overwhelming for sponsors and investigator.
4
DIFFERENCES B/W INDIAN-GCP & ICH-GCP
5
1. Investigator:
a. Qualification- The Indian
GCP (3.3.1) insists that the
investigator should be qualified
as per the requirement of the
Medical Council of India
(MCI).
b . Responsibility- accordingly
investigator should sign &
forward the data like CRF ,
results ,data analysis from
his/her centre to sponsor &
ethics committee
According to ICH GCP it is
not necessary to be registered
with MCI.
As per ICH GCP the
investigator has to provide a
summary of the outcome of
trial to the independent ethics
committee
Indian GCP ICH GCP
6
2. Investigator &
sponsor’s SOPs: the
Indian guideline
mandates that the sponsor
& the investigator should
sign a copy of the
standard operating
procedure.
Besides, the
investigator and his
staff have to be aware
& comply with the
SOPs
Indian GCP ICH GCP
7
3. Power of IEC :
accordingly IEC has
power to order
discontinuation of a trial
if the IEC finds the goals
have been achieved or
unequivocal results
obtained.
As per ICH GCP, it is the
responsibility of the
Independent Data
Monitoring Committee
(IDMC) established by
sponsor.
Indian GCP ICH GCP
8
4. Essential items for
informed consents:
Indian guidelines cover
issues of biological
samples in the informed
consents form.
As per ICH GCP there is
no information regarding
the biological sample in
informed consents form.
Indian GCP ICH GCP
9
5. Monitor:
a. Qualification: Indian GCP
guidelines suggest that the
monitor should have adequate
medical, pharmaceutical and/or
scientific experience.
b. Responsibility: Monitor is
supposed to inform the sponsor
and IEC in case any
unwarranted deviation from
protocol or any transgression
from principles of GCP.
No such specification have
been mentioned as it is an
international guide line.
As per ICH-GCP monitor has
to verify that the documents
provided by the investigator
are legible.
Indian GCP ICH GCP
10
6. Document retention:
Indian GCP mandates that
the sponsor should make
arrangements for safe and
secure custody of all study
related documents and
material for a period of
three years after the
completion of the study or
submission of the data to
the regulatory authority
As per ICH GCP
documents are maintained
for 2 yr after getting the
marketing approval
Indian GCP ICH GCP
11
6.Drug label:
accordingly the drug
label should contain
name and contact no.
of investigator & name
of the institution
As per ICH GCP it is not
so because this will
lead to practical
difficulties in global
trials.
Indian GCP ICH GCP
12
7. No. of IEC members :
maximum no. IEC
members are 12-15.
female gender is must.
Maximum no. of IEC
members are 5.
Both sexes are preferred.
etc.
Indian GCP ICH GCP
REFERENCES
 http://www.bioinformatics-india.com
 http://www.authorstream.com
 http://www.clinicalresearchsociety.org
13
14
15

Differences between indian gcp and ich-gcp

  • 1.
  • 2.
    INDEX 1> Introduction: GoodClinical Practice (GCP) 2> Differences b/w Indian-GCP & ICH-GCP. 3> Conclusion. 4> References. 2
  • 3.
    INTRODUCTION Good clinical practice(GCP) is an international ethical & scientific quality standard for designing, conducting , recording & reporting trials that involve the participation of human subjects. Compliance with standard provides public assurance that the rights, safety & well being of trial subjects are protected, consistent with the principle that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible. 3
  • 4.
    The Indian versionof GCP is based on the ICH-GCP, but there are key differences between the two. Some of the guidelines found in the Indian version result in the difficult methodology which becomes overwhelming for sponsors and investigator. 4
  • 5.
    DIFFERENCES B/W INDIAN-GCP& ICH-GCP 5 1. Investigator: a. Qualification- The Indian GCP (3.3.1) insists that the investigator should be qualified as per the requirement of the Medical Council of India (MCI). b . Responsibility- accordingly investigator should sign & forward the data like CRF , results ,data analysis from his/her centre to sponsor & ethics committee According to ICH GCP it is not necessary to be registered with MCI. As per ICH GCP the investigator has to provide a summary of the outcome of trial to the independent ethics committee Indian GCP ICH GCP
  • 6.
    6 2. Investigator & sponsor’sSOPs: the Indian guideline mandates that the sponsor & the investigator should sign a copy of the standard operating procedure. Besides, the investigator and his staff have to be aware & comply with the SOPs Indian GCP ICH GCP
  • 7.
    7 3. Power ofIEC : accordingly IEC has power to order discontinuation of a trial if the IEC finds the goals have been achieved or unequivocal results obtained. As per ICH GCP, it is the responsibility of the Independent Data Monitoring Committee (IDMC) established by sponsor. Indian GCP ICH GCP
  • 8.
    8 4. Essential itemsfor informed consents: Indian guidelines cover issues of biological samples in the informed consents form. As per ICH GCP there is no information regarding the biological sample in informed consents form. Indian GCP ICH GCP
  • 9.
    9 5. Monitor: a. Qualification:Indian GCP guidelines suggest that the monitor should have adequate medical, pharmaceutical and/or scientific experience. b. Responsibility: Monitor is supposed to inform the sponsor and IEC in case any unwarranted deviation from protocol or any transgression from principles of GCP. No such specification have been mentioned as it is an international guide line. As per ICH-GCP monitor has to verify that the documents provided by the investigator are legible. Indian GCP ICH GCP
  • 10.
    10 6. Document retention: IndianGCP mandates that the sponsor should make arrangements for safe and secure custody of all study related documents and material for a period of three years after the completion of the study or submission of the data to the regulatory authority As per ICH GCP documents are maintained for 2 yr after getting the marketing approval Indian GCP ICH GCP
  • 11.
    11 6.Drug label: accordingly thedrug label should contain name and contact no. of investigator & name of the institution As per ICH GCP it is not so because this will lead to practical difficulties in global trials. Indian GCP ICH GCP
  • 12.
    12 7. No. ofIEC members : maximum no. IEC members are 12-15. female gender is must. Maximum no. of IEC members are 5. Both sexes are preferred. etc. Indian GCP ICH GCP
  • 13.
  • 14.
  • 15.